Press Releases - 2020-11-30

Date	Title	Company
30-Nov-2020	PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia	PTC Therapeutics, Inc.
30-Nov-2020	Nuritas Puts Muscle Health Peptides to the Test in Human Trials	Nuritas
30-Nov-2020	Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis	ABIVAX
30-Nov-2020	Pandemic to delay cancer advances by nearly 18 months, researchers fear	The Institute of Cancer Research
30-Nov-2020	New guide helps unlock NHS for innovators to accelerate uptake of digital health technology	BOEHRINGER INGELHEIM IN
30-Nov-2020	Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets	Kaia Health and Chiesi Group
30-Nov-2020	Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis	Sanofi
30-Nov-2020	Khondrion shares progress of sonlicromanol development programme at Mitochondrial Medicine 2020 virtual conference	Khondrion
30-Nov-2020	VAL201 Clinical Trial Full Data Results	ValiRx plc
30-Nov-2020	Forxiga approved in Japan for chronic heart failure	AstraZeneca
30-Nov-2020	Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization	Moderna
30-Nov-2020	Autolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine	Autolus Therapeutics plc
30-Nov-2020	ViiV Healthcare and the Medicines Patent Pool expand access to dolutegravir-based regimens for people living with HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia with innovative new licensing agreement	ViiV Healthcare
30-Nov-2020	M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG - Group	M1 Kliniken AG
30-Nov-2020	Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021 according to CPhI Report	CPhI
30-Nov-2020	First results of the DiabetRisk study – Over 8% of patients identified with undiagnosed diabetes or pre-diabetes at dental practices	Sunstar
30-Nov-2020	New Publication from I-SPY 2 Trial Highlights Signatera's Ability to Predict Treatment Outcomes in Neoadjuvant Breast Cancer Patients	Natera, Inc.
30-Nov-2020	HAEMATO AG: Expansion of the board of directors: Strengthening the strategic and operative implementa-tion of the product business in the Haemato Group	HAEMATO AG
30-Nov-2020	Elevar Therapeutics Appoints Gus Aromin as Vice President of Regulatory Affairs	Elevar Therapeutics
30-Nov-2020	LGC's high-throughput PCR testing system for SARS-CoV-2 detection, submitted for Emergency Use Authorisation, capable of processing up to 35,000 tests per day	LGC